The $7 Billion ‘Abandoned’ Drug: Edward Van Wezel's Story From For Blood and Money Ep. 1044 Dan SferaMarch 23, 2026Comment
The Biotech Rebound is Here: But is the CRO AIpocalypse Real? Ep. 1043 Dan SferaMarch 19, 2026Comment
The 'Blacklist' Secret: Do CROs Actually Have a List of Bad Sites? Ep. 1042 Dan SferaMarch 18, 2026Comment
How to Survive an FDA Audit: Real Case Studies on PI Responsibility in Clinical Research Ep. 1039 Dan SferaMarch 10, 2026Comment
The Clinical Research Consolidation Curve: How to Value and Sell Your Site Ep. 1038 Dan SferaMarch 9, 2026Comment
The Trustless Era: How AI & Data are Changing Clinical Research Site Metrics Ep. 1036 Dan SferaFebruary 27, 2026Comment
The Architect of PDUFA - 40 Years Inside the FDA with Marc Scheinesen Ep. 1035 Dan SferaFebruary 25, 2026Comment
The Clinical Research "Gig Economy": Navigating Contract Roles Today Ep. 1034 Dan SferaFebruary 24, 2026Comment
Why Good Drugs Fail Clinical Trials: The "Sponsor Monster" Tells AllEp. 1033 Dan SferaFebruary 24, 2026Comment
Clinical Research's Unspoken Truths: Why Some Sites Fail, Others Skyrocket Ep. 1031 Dan SferaFebruary 17, 2026Comment
Ray Dalio’s Stage 6: The Survival Guide for the Golden Decade of Clinical Research Ep. 1030 Dan SferaFebruary 17, 2026Comment
She Was Kicked Out of Zambia for Spying... Now She Exposes Medical Fraud - Edye Edens Ep. 1028 Dan SferaFebruary 10, 2026Comment
How to Sell Your Clinical Research Site Without Killing the Deal Ep. 1027 Dan SferaFebruary 9, 2026Comment
The End of the Research Site as We Know It? My Appearance On @notetofilepodcast Ep. 1025 Dan SferaJanuary 28, 2026Comment
